The market opportunities lie in expanding GMP-compliant vaccine production facilities globally, ensuring quality raw material supply, and enhancing risk management for safety in production.

CARY, N.C., Sept. 22, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of manufacturing and quality management solutions for regulated industries, is proud to announce its recognition as the #2 ...

As discussed in the Product Perspective, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents a major shift in cosmetic industry regulations. This article is one of a series of ...

SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, Entos Pharmaceuticals didn’t want to depend on contract manufacturers for the drug ...

Manufacturers are usually subjected to a diverse variety of regulations typically established by international and regional bodies. Failure to comply can result in the loss of authorization and ...

ProBioGen has been selected to operate the process development and GMP production facility for Advanced Therapy Medicinal ...

EDMONTON, Alberta & SAN DIEGO--(BUSINESS WIRE)--Entos Pharmaceuticals (Entos), a clinical-stage biotechnology company developing genetic medicines with its proprietary Fusogenix proteolipid vehicle ...

Key Manufacturing Milestone Strengthens PolyPid’s Position as it Advances Towards Global Commercialization of D-PLEX₁₀₀ ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

Aurora Cannabis plans to upgrade its facility in Germany, to increase its cannabis production and improve cost efficiency. The Edmonton, Alberta-based cannabis company said it will invest over the ...